DELRAY BEACH, Fla., May 21, 2026 /PRNewswire/ -- According to MarketsandMarkets™, the Cell Isolation Market/Cell Separation Market is projected to grow from about USD 4.39 billion in 2026 to USD 7.97 billion by 2031, at a CAGR of 12.7%.

Browse 630 market data Tables and 30 Figures spread through 470 Pages and in-depth TOC on 'Cell Isolation Market/Cell Separation Market- Global Forecast to 2031'

Cell Isolation Market Size & Forecast:

• Market Size Available for Years: 2025–2031
• 2026 Market Size: USD 4.39 billion
• 2031 Projected Market Size: USD 7.97 billion
• CAGR (2026–2031): 12.7%

Cell Isolation Market Trends & Insights:

• By product, consumables accounted for the largest share, at 65%, of the cell isolation market in 2025.
• By technique, centrifugation-based cell isolation accounted for the largest share of the cell isolation market in 2025.
• North America accounted for the largest share, at 43%, of the cell isolation market in 2025.

Download PDF Brochure @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=103931479

The cell isolation market is expanding as pharmaceutical and biotechnology companies, clinical laboratories, and academic research institutes increasingly adopt cell separation technologies to support drug discovery, cell-based research, regenerative medicine, immunology, cancer biology, and cell therapy development. Cell isolation tools are used to separate, enrich, and purify specific cell populations, including immune cells, stem cells, circulating tumor cells, leukocytes, and primary cells, for downstream analysis and therapeutic applications. Rising demand for viable, high-purity cell populations in translational research, single-cell analysis, biomarker discovery, and cell and gene therapy manufacturing is accelerating the adoption of magnetic-activated cell sorting, fluorescence-activated cell sorting, density gradient separation, microfluidics, and automated cell-processing platforms. In addition, ongoing advances in closed-system processing, label-free separation, automation, and standardized isolation kits are improving reproducibility, scalability, and workflow efficiency, thereby supporting broader market expansion.

By cell type, the human cells segment held the largest share of the cell isolation market in 2025.

By cell type, the cell isolation market is segmented into human cells and animal cells. In 2025, human cells accounted for the largest market share. This is primarily due to the high demand for human-derived immune cells, stem cells, circulating tumor cells, leukocytes, and primary cells across drug discovery, translational research, cell and gene therapy development, cancer biology, and clinical diagnostics. Human cell isolation is widely used in immunology studies, biomarker validation, personalized medicine, and therapeutic development, where biologically relevant human samples are essential for accurate research outcomes. The growing adoption of single-cell analysis, immune profiling, and GMP-compatible cell therapy workflows further supports the dominance of the human cells segment in the market.

Request Sample Pages @ https://www.marketsandmarkets.com/requestsampleNew.asp?id=103931479

By instruments, the centrifuges segment held the largest share of the cell isolation market in 2025.

By instruments, the cell isolation market is segmented into centrifuges, cell sorters, magnetic-activated cell separator systems, filtration systems, and other instruments. In 2025, centrifuges accounted for the largest market share. This is due to their widespread use in routine cell separation, sample preparation, density gradient centrifugation, washing, pelleting, and enrichment workflows. Centrifuges are commonly used across academic laboratories, biotechnology companies, pharmaceutical research facilities, clinical laboratories, and cell processing units because they are cost-effective, scalable, and compatible with multiple sample types. Their continued use in peripheral blood mononuclear cell isolation, leukocyte separation, stem cell enrichment, and primary cell preparation supports their leading position in the instruments segment.

North America accounted for the largest share of the market in 2025.

In 2025, North America held the largest share of the cell isolation market. This is supported by a strong biopharmaceutical base, early adoption of advanced cell-separation technologies, substantial investment in cell and gene therapy research, and well-established biomedical research infrastructure. The US leads the region in immunology research, oncology studies, stem cell research, single-cell analysis, and clinical cell therapy development. The presence of major market players, cell therapy companies, academic medical centers, clinical laboratories, and specialized research institutes continues to drive demand for cell isolation products. Ongoing advancements in automated cell isolation, closed-system processing, and GMP-grade consumables are further supporting market growth in North America.

Inquire Before Buying @ https://www.marketsandmarkets.com/Enquiry_Before_BuyingNew.asp?id=103931479

Top Companies in Cell Isolation Market:

The Top Companies in Cell Isolation Market include Danaher (US), Merck KGaA (Germany), Thermo Fisher Scientific Inc. (US), BD (US), Sartorius AG (Germany), Agilent Technologies, Inc. (US), Bio-Rad Laboratories, Inc. (US), QIAGEN (Netherlands), F. Hoffmann-La Roche Ltd (Switzerland), Revvity (US), and Corning Incorporated (US), among others.

Browse Adjacent Markets: Biotechnology Market Research Reports & Consulting

Related Reports:

Single Cell Analysis Market - Global Forecast to 2030

Cell Therapy Technologies Market - Global Forecast to 2030

Cell Expansion Market - Global Forecast to 2029     

Cell Counting Market - Global Forecast to 2029

Gene Therapy Market - Global Forecast to 2032

About MarketsandMarkets™ 

MarketsandMarkets™ has been recognized as one of America's Best Management Consulting Firms by Forbes, as per their recent report.

MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. With the widest lens on emerging technologies, we are proficient in co-creating supernormal growth for clients across the globe.

Today, 80% of Fortune 2000 companies rely on MarketsandMarkets, and 90 of the top 100 companies in each sector trust us to accelerate their revenue growth. With a global clientele of over 13,000 organizations, we help businesses thrive in a disruptive ecosystem.

The B2B economy is witnessing the emergence of $25 trillion in new revenue streams that are replacing existing ones within this decade. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines – TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.

Built on the 'GIVE Growth' principle, we collaborate with several Forbes Global 2000 B2B companies to keep them future-ready. Our insights and strategies are powered by industry experts, cutting-edge AI, and our Market Intelligence Cloud, KnowledgeStore™, which integrates research and provides ecosystem-wide visibility into revenue shifts.

MarketsandMarkets™ SalesPlay is an AI-driven Revenue Intelligence Co-Pilot designed to help revenue teams prioritize the right accounts, identify critical changes early, and surface opportunities ahead of demand, so pipeline builds naturally and deals close with greater consistency.

To find out more, visit www.MarketsandMarkets™.com or follow us on Twitter , LinkedIn and Facebook .

Contact:
Mr. Rohan Salgarkar
MarketsandMarkets™ INC.
1615 South Congress Ave.
Suite 103, Delray Beach, FL 33445
USA: +1-888-600-6441
Email: sales@marketsandmarkets.com
Visit Our Website: https://www.marketsandmarkets.com/

Logo: https://mma.prnewswire.com/media/1868219/5909825/MarketsandMarkets_Logo.jpg

View original content:https://www.prnewswire.com/news-releases/cell-isolation-marketcell-separation-market-worth-7-97-billion-by-2031--marketsandmarkets-302778616.html

SOURCE MarketsandMarkets